Mouse Monoclonal HIV1 Nef antibody. Suitable for WB, ELISA, ICC/IF and reacts with Recombinant full length protein - Human immunodeficiency virus, Human immunodeficiency virus samples. Cited in 19 publications.
pH: 7.4
Preservative: 0.1% Sodium azide
Constituents: PBS
WB | ELISA | ICC/IF | |
---|---|---|---|
Human immunodeficiency virus | Predicted | Expected | Expected |
Recombinant full length protein - Human immunodeficiency virus | Tested | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Human immunodeficiency virus | Dilution info 1/500 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human immunodeficiency virus | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human immunodeficiency virus | Dilution info 1/5000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Human immunodeficiency virus | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human immunodeficiency virus | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Human immunodeficiency virus | Dilution info - | Notes - |
Select an associated product type
Factor of infectivity and pathogenicity, required for optimal virus replication. Alters numerous pathways of T-lymphocyte function and down-regulates immunity surface molecules in order to evade host defense and increase viral infectivity. Alters the functionality of other immunity cells, like dendritic cells, monocytes/macrophages and NK cells. In infected CD4(+) T-lymphocytes, down-regulates the surface MHC-I, mature MHC-II, CD4, CD28, CCR5 and CXCR4 molecules. Mediates internalization and degradation of host CD4 through the interaction of with the cytoplasmic tail of CD4, the recruitment of AP-2 (clathrin adapter protein complex 2), internalization through clathrin coated pits, and subsequent transport to endosomes and lysosomes for degradation. Diverts host MHC-I molecules to the trans-Golgi network-associated endosomal compartments by an endocytic pathway to finally target them for degradation. MHC-I down-regulation may involve AP-1 (clathrin adapter protein complex 1) or possibly Src family kinase-ZAP70/Syk-PI3K cascade recruited by PACS2. In consequence infected cells are masked for immune recognition by cytotoxic T-lymphocytes. Decreasing the number of immune receptors also prevents reinfection by more HIV particles (superinfection). Down-regulates host SERINC3 and SERINC5 thereby excluding these proteins from the viral particles. Virion infectivity is drastically higher when SERINC3 or SERINC5 are excluded from the viral envelope, because these host antiviral proteins impair the membrane fusion event necessary for subsequent virion penetration. Bypasses host T-cell signaling by inducing a transcriptional program nearly identical to that of anti-CD3 cell activation. Interaction with TCR-zeta chain up-regulates the Fas ligand (FasL). Increasing surface FasL molecules and decreasing surface MHC-I molecules on infected CD4(+) cells send attacking cytotoxic CD8+ T-lymphocytes into apoptosis. Plays a role in optimizing the host cell environment for viral replication without causing cell death by apoptosis. Protects the infected cells from apoptosis in order to keep them alive until the next virus generation is ready to strike. Inhibits the Fas and TNFR-mediated death signals by blocking MAP3K5/ASK1. Decreases the half-life of TP53, protecting the infected cell against p53-mediated apoptosis. Inhibits the apoptotic signals regulated by the Bcl-2 family proteins through the formation of a Nef/PI3-kinase/PAK2 complex that leads to activation of PAK2 and induces phosphorylation of host BAD. Extracellular Nef protein targets CD4(+) T-lymphocytes for apoptosis by interacting with CXCR4 surface receptors.
Protein Nef, 3'ORF, Negative factor, F-protein, nef
Mouse Monoclonal HIV1 Nef antibody. Suitable for WB, ELISA, ICC/IF and reacts with Recombinant full length protein - Human immunodeficiency virus, Human immunodeficiency virus samples. Cited in 19 publications.
pH: 7.4
Preservative: 0.1% Sodium azide
Constituents: PBS
This antibody reacts with the rNEF of HIV 1 subtype B and C,
Purified by affinty chromatography.
Also known as clone 01-002.
HIV1 Nef also known as Nef HIV Nef protein and Nef HIV protein is a small myristoylated protein with a mass of approximately 27 kDa. It expresses predominantly in the cytoplasm of HIV-1 infected cells. HIV1 Nef plays an important role in viral pathogenicity by manipulating host cell machinery to favor viral replication and immune escape. The protein affects the host cell's plasma membrane and endosomal compartments where it modifies the trafficking of various cell surface molecules.
Nef affects several cellular processes to promote viral persistence and disease progression. It disrupts normal cellular signaling and acts as part of larger protein complexes that interact with host proteins. For instance it is known for its interaction with proteins like AP-1 which Nef uses to alter the re-routing of MHC-I molecules to lysosomes. This results in reduced exposure of infected cells to the immune system and highlights its role in immune evasion.
Nef engages in interference with immune and cellular signaling pathways. It tightly interacts with the PI3K/Akt signaling pathway important for cell survival and proliferation thereby assisting the virus in sustaining a hospitable cellular environment. Nef also partners with Src family kinases further supporting its functions in reprogramming cellular processes and enhancing viral replication.
HIV1 Nef is intimately related to HIV/AIDS pathogenesis. It contributes significantly to the immunodeficiency observed in infected individuals by modulating CD4 and CTLA-4 downmodulation affecting immune signaling and response. Furthermore Nef aligns with Tat protein in HIV-infected cells enhancing the pathological effects seen in the neurodysfunction often associated with disease progression illustrating its role in complex interactions that worsen HIV-related complications.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-HIV1 Nef antibody [3D12] (ab42355)
Lane 1: Recombinant HIV1 Nef (B subtype)
Lane 2: Protein size marker
Predicted band size: 24 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com